European Heart Journal

Article	Citations
Meet the European Society of Cardiology Gold Medallists 2022	2884
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	2621
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	2033
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	1908
Strengthening cardiovascular trials across Australia and New Zealand—the Alliance for Cardiovascular Trials (ANZACT) Network	1598
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	1419
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	1272
Obituary Joep Perk	1249
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	1042
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	953
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	936
Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	847
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	809
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	807
Pulmonary haemodynamics and pulmonary congestion: where are we now?	763
The Antwerp score: is this the ‘new hope on the horizon’?	505
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	486
A rare case of a dorsal mass caused by descending thoracic aortic dissection	457
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	417
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	392
Intricacies of aortic risk assessment studies: not a simple matter	364
Corrigendum to: Backup natural pacemaker found in the heart	335
Beyond modality: unaddressed variables and comorbidities in exercise interventions for coronary artery disease	281
Breakthrough outflow tract unlocking: modified transapical balloon-assisted transseptal mitral annuloplasty for high-risk mitral valve-in-ring patients	237
Arterial conduits for coronary bypass grafting: the set-point concept	235

Bulgarian Society of Cardiology: 50 years on	227
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	215
Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	212
Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up	205
Synthetic assessment of cardiac autonomic modulation and Baevsky stress index in patients with synucleinopathies	204
From a club of friends to an institution: past successes and future challenges for the European Society of Cardiology	204
Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score	186
Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation	183
Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records	179
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	176
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome	176
Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study	173
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance	168
Preserved left ventricular ejection fraction with abnormal myocardial work in sepsis	168
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation	162
Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes	161
Comparison of rapid test for high-sensitivity troponin I with laboratory high-sensitivity troponin T in patients with acute chest pain - a prospective monocentric study	161
Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies	158
Air pollutants, genetic susceptibility, and abdominal aortic aneurysm risk: a prospective study	156
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial	156
Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University	155
Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation	152
Nocturnal heat exposure and stroke risk	149
Correction to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary sy	149
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-T	147
Beyond reproductive health: the cardiovascular risks of endometriosis	146
Weekly Journal Scan: The promise of small interfering RNA in reducing lipoprotein(a)	145
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications	139
Breathing danger: linking air pollution to cardiovascular disease and increased risk of abdominal aortic aneurysm	137
Blood biomarkers in left-sided valvular heart disease	136
The COVID-19 pandemic and heart failure: lessons from GUIDE-HF	134
Novel DES cardiomyopathy presenting with lifelong syncope: diagnostic breakthrough via multimodal imaging and insertable cardiac monitor	134
Dementia in individuals with severe hypercholesterolemia: Korean nationwide cohort study	134
The gender difference in cause of death in Japanese atrial fibrillation patients: The Fushimi AF Registry	132
Differences in left atrial stain, endothelial glycocalyx, arterial elasticity and myocardial efficiency between ESUS, lacunar, cardioembolic and atherosclerotic type of stroke	132
Recent cardiac rehabilitation and its impact on cardiopulmonary exercise test variables in Brazilian cardiac transplant recipients	132
Cardiac troponin fragmentation in marathon runners. The MaraCat2 study	130
Multiparametric risk predictions for morbidity and mortality in patients with pulmonary arterial hypertension: insights from a nation-wide registry	130
Acute infections and inflammatory biomarkers in patients with acute pulmonary embolism	130
Echocaridographic assessment of pulmonary hypertension: improving the probability	129
Twenty-year trends in peripheral artery disease, lower extremity revascularization, and lower extremity amputation in newly diagnosed type 2 diabetes	128
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease	127
Physiological disease pattern as assessed by PPGI in vessels with FFR and iFR discordance	126
Cumulative accelerometer-based light physical activity from childhood through young adulthood progressively decreases left ventricular mass in British youth: a 13-year longitudinal study	125
Clinical outcomes of deferred lesions by IVUS versus FFR-guided treatment decision: the FLAVOUR trial substudy	124
Novel cardiovascular magnetic resonance imaging heterogeneity biomarkers to diagnose and predict cardiovascular disease: a UK Biobank CMR strain study	123
T regulatory cells lose their protective phenotype in patients with coronary artery disease (CAD)	121
Continuous monitoring of heart failure biomarker using a sensitive graphene-based electrical sensor	121
Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes	120
Association between the changes in walking speed during 6 months after discharge and subsequent prognosis in older patients with heart failure: report from a multicenter prospective cohort study	119

Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions	119
Left main coronary artery dimension and variation in Thai population	118
New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)	115
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	115
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team	114
Deep learning for fully automated echocardiographic measurements of left ventricular wall thickness and chamber dimensions in the parasternal long-axis view	112
Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes	110
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	110
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	108
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	108
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	107
Survival penalty in patients undergoing transcatheter versus surgical aortic valve replacement: is it just a question of frailty? Insights from a large cohort with demographic matching	103
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	103
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function	103
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	103
Implementing dynamic atrioventricular delay optimization for cardiac resynchronization therapy: an economic analysis in the EU5 countries	102
Practicing what you preach. Do cardiology trainees in the United Kingdom follow the lifestyle advice that they would give to patients?	101
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	100
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	99
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	99
Factors for incorrect automated atrial fibrillation identification in large-scale screening	99
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	99
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	96
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report	95
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study	95
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	94
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure	94
Quantitative assessment of myocardial fibrosis by digital image analysis: an adjunctive tool for pathologist ground truth	93
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	93
Impact of the thin-walled sheath on the distal radial artery occlusion: a randomized trial	91
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study	91
Prognostic role of data transmitted by implanted cardiac electric devices in patients with advanced heart failure referred for heart transplantation	90
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	90
Comparative study of the effects of left ventricular and biventricular pacing on indices of cardiac function and clinical status of heart failure patients: preliminary results of READAPT study	90
The role of seasonal influenza immunisation in cardiovascular care: a survey of cardiologists	89
Ultra-processed food consumption and risk of cardiovascular mortality in Australia: preliminary results from prospective observational study	88
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarction	87
Acute deterioration in dyssynchrony and systolic function from Lot-CRT to LBBB pacing	87
Comparison of fully angiography-derived versus a hybrid of angiography and pressure-wire-derived approach to assess coronary microvascular resistance: the OxAMI-Hybrid study	87
Dynamic changes of excessive trabeculation in dilated cardiomyopathy: a longitudinal cardiovascular magnetic resonance study	87
Trimethylamine N-oxide as a Novel Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling in ST-Elevation Myocardial Infarction Patients	86
Comparative effects of ranolazine and trimetazidine on cardiac structure and exercise capacity in a healthy rat model: a new doping agent?	86
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain	86
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study	86
The added value of advanced echocardiography in dilated cardiomyopathy: looking at the right heart	86
Feasibility and efficacy of a novel 6 french sheathless guiding catheter equipped with peel-off type external dilator for PCI with distal radial approach - a Japanese multicenter study	85
Endothelial dysfunction in acute coronary syndrome: a complex association with cardiovascular risk factors, sleep quality and cardiorespiratory capacity	85
Safety and efficacy of perventricular device closure of ventricular septal defects in children	85
Associated factors and clinical implications of dynamic changes in late gadolinium enhancement after acute myocarditis	84
Long-term outcomes following DCB vs. DES for ISR treatment	84
Plaque phenotyping using deep learning in optical coherence tomography imaging	84
Survival in STEMI in resource limited settings - obstacles and potential solutions. Critical lesson learnt thorough a prospective observational study	84
Prediction of all-cause mortality in cardiovascular patients by using machine learning models	83
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation	83
Ischemic stroke in patients with congenital heart disease and atrial fibrillation	82
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography	82
Predictors of 1-year follow-up period MACE in patients with NSTEMI	82
Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study	80
NOAC in adult congenital heart disease patients: a single-center experience	79
Prevalence of attention deficit/hyperactivity disorder (ADHD) in congenital heart diseases (CHD), a systematic review and meta-analysis	78
Effect of LPA gene on CAD risk among diabetic patients	78
Prognostic value of cardiac magnetic resonance in elderly patients soon after ST-segment elevation myocardial infarction	78
Usefulness of CineECG method in identification of P-wave morphology variants in an elderly epidemiologic cohort	77
The specificity of cardiac troponin elevations for myocardial infarction declines with age	76
Phenotyping of heart failure with preserved ejection faction using health electronic records and echocardiography	76
Phenotyping coronary plaque by computed tomography in premature coronary artery disease	76
Echocardiography in acute pulmonary embolism for the prediction of subsequent CTEPH	76
Impaired right ventricular strain is associated with worse prognosis in patients with liver cirrhosis	75
How can the detection of AF be improved? Insights from patient journeys and primary care clinicians	74
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study	74
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention	74
Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions	74
Discovering an unknown risk. The unnoticed, potientially life-threatening risk to people with an inherited cardaic arrhythmia during the non-cardiac perioperative period.	74
The impact of worsening heart failure (WHF) status on subsequent outcomes among patients with HFrEF: History of WHF events is associated with worse subsequent outcomes regardless of extent of GDMT	74
Prediction of outcome in malignant hypertension patients using machine learning: a report from the West Birmingham malignant hypertension registry	73
Safety of electrophysiological study in atrioventricular block risk stratification in new-onset persistent left bundle brunch block following transcathether aortic valve implantation	73
Cardiovascular safety of non-steroidal anti-inflammatory drug use for gout: A Danish nationwide case-crossover study	73
Artificial intelligence-assisted examination of cardiac health status through electrocardiogram	72
Cardiovascular etiologies and risk factors of survival outcomes after resuscitation for out-of-hospital cardiac arrest: data from the KoCARC registry	72
A larger reduction of spatial mean QRS-T angle during cardiac resynchronisation therapy is associated with a lower risk of mortality and heart failure hospitalisation	72

Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease	72
The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in epicardial adipose tissue modulation: a meta-analysis	72
Quantifying cardiac tissue heterogeneity using high-density grid catheter: validation in porcine model	71
Blood pressure polygenic risk scores associate with resistant hypertension in individuals with type 1 diabetes	71
Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial	71
Calculation of intraprocedural hemodynamics with computational functional dynamic in mitral valve edge-to-edge repair	71
Mortality and predictors of death in women and men with congestive heart failure of different types of cardiomyopathies	70
Further prognostic stratification in patients with oscillatory ventilation with exercise: is there more to it than just ups and downs?	70
The novel P-Wave Area index predicts low voltage areas in patients undergoing pulmonary vein isolation for treatment of atrial fibrillation	70
Is left atrial reservoir strain a superior modality to predict acute left ventricular failure in hypertensive patients	70
Prognostic impact of the serial change of a systemic inflammation-nutrition index in patients with heart failure with preserved ejection fraction: insights from pursuit-hfpef registry	69
Screening for subclinical atherosclerosis in patients clinically diagnosed with familial hypercholesterolemia and determination of imaging-guided patient management strategy	68
Association between quantitative flow ratio and non-target-vessel-related events before planned staged percutaneous coronary intervention in patients with acute coronary syndrome	67
ARNI effects in HFrEF. Risk reduction beyond LVEF	67
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice	67
Clinical profile and incidence of 36-month cardiovascular events in patients with MINOCA: a regional registry of 126 patients in a tertiary cardiology hospital	66
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period	66
Reduced 3D-left atrium ejection fraction predicts development of atrial fibrillation in patients with hypertrophic cardiomyopathy	66
Cardiometabolic outcomes in patients with overweight and obesity undergoing weight loss trials : a network meta-analysis	66
Microtransesophageal echocardiographic guidance of patent foramen ovale percutaneous closure	66
Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation	65
Prognostic role of early cardiac magnetic resonance in myocardial infarction with non-obstructive coronary arteries	65
Cardiac troponin elevation and mortality in takotsubo syndrome: new insights from the International Takotsubo (InterTAK) registry	64
Sacubitril-valsartan activates pAMPK and reduces NLRP3, MyD88, cytokines/growth factors and DAMPs in doxorubicin-treated mice improving longitudinal strain and ejection fraction	64
Influence of radiotherapy on cardiac implantable device lead parameters	64
Ten years survival benefit of CABG or PCI based on individual prediction	63
Machine learning can accurately detect abnormal aortic valves in CMR	63
Lipoprotein(a) and cardiovascular prognosis of familial dyslipidemias: data from a 10-year follow-up study	63
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: design, rationale, and first results of the Zabrze-Lip(a)R Registry	62
Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm	62
Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry	61
Machine learning model using cardiovascular magnetic resonance to predict cardiovascular events in asymptomatic patients with known CAD	61
Left atrial function and long-term survival after cardiac resynchronization therapy	61
Microvascular dysfunction and absolute coronary blood flow after percutaneous coronary intervention of a chronic total occlusion	61
24h SCAI stage reclassification to predict outcome. Insights from the prospective Altshock-2 registry	60
Combined cardiopulmonary test and exercise Doppler echocardiography in systemic sclerosis	60
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation: observations from the GARFIELD-AF registry	60
Effect of sacubitril/valsartan and empagliflozin on systemic inflammation and scar remodeling in a swine model of myocardial infarction	60
Variations in atrial fibrillation screening after ischemic stroke or transient ischemic attack in Sweden	59
Characterisation of metabolic phenotype in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study	59
MINOCA due to vasospasm compared to other mechanisms: patients characteristics, evolution and prognosis	59
How to predict myocardial injury in patients with large ischaemic burden identified during stress echocardiography?	58
Pulmonary artery aneurysm in pulmonary arterial hypertension associated with congenital heart disease	58
Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS	58
Primary care screening and prevention of heart failure coordinated by cardiologist in rural areas	58
The impact of hydrostatic pressure on fractional flow reserve in saphenous vein grafts	58
Targeting Neurofibromin 2 (NF2) prevents endothelial dysfunction in obesity: a study in mice and humans	58
Anticoagulation and stroke in hospitalized patients newly diagnosed with secondary atrial fibrillation: a population-based cohort study	58
Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: insights From the IMPEDANCE-HF Trial	57
Early quantitative pupillary response parameters have high predictive value for 30-day mortality in patients resuscitated from out-of-hospital cardiac arrest	57
Differential efficacy and safety of oral anticoagulation in atrial fibrillation patients with or without comorbid vascular disease: insights from the GARFIELD-AF registry	57
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry	57
Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease	57
A novel technology for heart failure that utilizes the respiratory effort to shift fluids from the lung and alleviate cardiac workloads; feasibility study in sheep	57
Efficacy of controlvit as a complementary strategy in reducing hospitalizations in patients with heart failure. Randomized clinical trial	57
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study	57
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction	56
Risk stratification and prognosis in pulmonary arterial hypertension: the Singapore experience	56
Demographic, clinical characteristics, managements strategies and in-hospital outcomes of patients enrolled in prospective nationwide SCAD registry	56
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study	56
Ultrasonographic and functional evaluation of forearm circulation with occluded radial artery	56
Changes in the immune cell landscape in the infarcted mouse heart	56
Heavy weekly alcohol consumption versus binge drinking after an acute coronary syndrome and risk of major adverse cardiovascular events at one year follow up	55
Safety and efficacy of cerebral embolic protection devices in transcatheter aortic valve implantation: a meta-analysis	55
Estimation of antihypertensive effect after initiating continuous positive airway pressure treatment in Japanese patients with sleep disordered breathing	55
Ethnic disparity in the care and management of non-ST-segment elevation myocardial infarction and its impact on short-term and long-term survival: a long-term study of a national registry	55
Various arrhythmia types and their day-by-day occurrence rates over a 14-day period using a P-wave sensitive ambulatory ECG monitored population	55
Biomarker profiles of favorable ventricular remodeling in heart failure patients with reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial	54
Participation of epicardial connection in transverse conduction across the crista terminalis in patients with upper and lower loop reentry atrial tachycardias	54
Sequential left ventricular electro-mechanical changes in left bundle branch pacing vs right ventricular pacing a two-center study	54
Comparison of multiple high sensitivity cardiac troponin assays for early low risk rule out of myocardial infarction: SCORECARD	54
Guideline-directed medical therapy and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction	53
COVID-19 vaccination in the pediatric age and risk for myocarditis	53
Afterload mismatch is associated with gender mismatch and negatively affect long-term outcome after heart transplant	53
Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes	53
Figuring out complete left ventricular reverse remodeling in tachycardiomyopathy	52
High resting coronary flow velocity predicts worse survival in chronic coronary syndromes	52
Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy	52
Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis	52
Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center	52
Reduction of triglyceride-rich lipoproteins with retatrutide in type 2 diabetes may be explained by concurrent reduction in ANGPTL3/8 levels	51
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry	51
Computed tomography plaque analysis identifies residual inflammation in recent acute myocardial infarction patients	51
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in CFA-challenged albino mice	51
Routine use of 3-dimensional zoom modality with 2-dimensional transesophageal echocardiography to decide the candidacy for transcatheter device closure of atrial septal defect	51
Bipolar ablation of refractory ventricular arrhythmias using a novel dedicated adapter. A multicenter study	51
Influence of lead extraction on tricuspid valve function	51
Artificial intelligence as a precision tool for predicting risk of in-hospital death after aortic valve replacement	50
Cardiac complications as a major predictor of in-hospital death in infective endocarditis using machine-learning algorithm analysis	50
Allied health professional-physician collaboration to enhance guideline-directed medical therapy of heart failure: expanding therapeutic opportunities	50
Interaction of inherited genetic variants in the NLRP3 inflammasome/IL-6 pathway with acquired clonal hematopoiesis to modulate mortality risk in patients with HFrEF	50
Infective endocarditis - characteristics and long-term outcomes in patients with congenital heart disease are distinct from those without congenital heart disease	50
Epidemiology, clinical characterization, and outcomes for heart failure with improved ejection fraction	50
Regional distribution of diffuse fibrosis in the basal and mid-ventricular AHA segments in patients with type 2 diabetes	50
Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)	49